Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: slo-niacin  upsher-smith  heart  health  cholesterol  cardiologists  niacin  dietary  supplement  hdl  multivu  58806  siro  clinpharm  clinical  research  medical  drug  development  trial  study  management  business  health  multivu  58672  torax  linx  medical  device  testimonial  gastroesophageal  reflux  disease  gerd  treatment  patients  health  multivu  60077  emdeon  atigeo  big  data  ytics  patient  care  payment  revenue  management  information  exchange  healthcare  multivu  59755  asuragen  fragilex  syndromes  autism  xpansion  interpreter  genetic  test  pregnancy  children  women  health  multivu  60719  antimicrobial  copper  clinical  trial  hospitals  healthcare  acquired  infections  icu  patients  health  multivu  61120  copper  development  greence  sustainability  arizona  health  sciences  innovative  construction  architects  multivu  61608  zensun  neucardin  chronic  congestive  heart  failure  chf  disease  treatment  research  multivu  61677  diabetes  technology  society  blood  sugar  level  glucose  monitor  patients  insulin  multivu  61870  clinical  research  training  institute  in  bangalore  sanofi  pasteur  clostridium  difficile  infection  vaccine  bacteria  cdiffense  health  study  multivu  62652  rehabilitation  institute  chicago  ric  health  hospitals  bionics  amputations  technology  multivu  63339 
Search // clinical
Results 49-60 of 101 for ' clinical ' (0 seconds)
Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) today presented interim findings from its BEST (Blastocyst Euploid Selective Transfer) trial, the first well-controlled clinical trial comparing in vitro fertilization (IVF) pregnancy rates in a group of women receiving a single embryo transfer (SET) with comprehensive chromosome screening (CCS) with a group receiving traditional morphology-based double embryo transfer (DET). The findings were presented at the American Society for Reproductive Medicine 68th Annual Meeting in San Diego, October 20-24, 2012. To view Multimedia News Release, go to http://www.multivu.com/mnr/58883-rmanj-best-trial-results-ivf-pregnancy-rates-women-asrm-annual-meeting
Added: 4389 days ago by MultiVuVideos
Runtime: 2m26s | Views: 1745 | Comments: 1
Not yet rated
 

 

 

Emdeon Inc., a leading provider of revenue and payment cycle management and clinical information exchange solutions, today announced the launch of Emdeon EDGE™, an integrated, technology-enabled solution that includes complete payment integrity and cost containment services designed to help detect improper healthcare claims and prevent inaccurate payments. To view Multimedia News Release, go to http://www.multivu.com/mnr/48121-emdeon-edge-payment-integrity-cost-management
Categories // Business 
Added: 4384 days ago by MultiVuVideos
Runtime: 1m16s | Views: 3544 | Comments: 0
Not yet rated
 

 

 

For the millions who suffer from Gastroesophageal Reflux Disease (GERD), a study published today in the New England Journal of Medicine (NEJM) provides clinical evidence of safety and effectiveness for a new, FDA-approved medical device. Torax Medical’s LINX® Reflux Management System was studied in a controlled, prospective, multicenter trial involving 14 U.S. and European medical centers as part of the FDA pre-market approval process. The patients were evaluated before and after treatment to determine the effect of the LINX System on their GERD using pre-defined success criteria, which included reduction of esophageal acid, improvement in quality of life and elimination of reflux medications. To view Multimedia News Release, go to http://www.multivu.com/mnr/60077-torax-medical-linx-reflux-management-system-clinical-study-published
Added: 4270 days ago by MultiVuVideos
Runtime: 4m58s | Views: 1336 | Comments: 0
Not yet rated
 

 

 

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced a collaboration with Atigeo™, a compassionate technology company that turns science into products and services for a wiser world. Together, Emdeon and Atigeo plan to explore the use of intelligent analytics layered on top of petabytes of healthcare data to improve health outcomes. To view Multimedia News Release, go to http://www.multivu.com/mnr/59755-emdeon-and-atigeo-intelligent-analytics-for-health-outcomes-himss13
Categories // Business  Science and Technology 
Added: 4263 days ago by MultiVuVideos
Runtime: 1m21s | Views: 2609 | Comments: 1
Not yet rated
 

 

 

Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ. To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
Added: 4242 days ago by MultiVuVideos
Runtime: 3m22s | Views: 1972 | Comments: 0
Not yet rated
 

 

 

Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards. To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
Added: 4174 days ago by MultiVuVideos
Runtime: 2m46s | Views: 1552 | Comments: 0
Not yet rated
 

 

 

Inspired by its surrounding southwestern landscape, the Health Sciences Education Building (HSEB) at The University of Arizona College of Medicine-Phoenix is one of the most innovative construction projects in the United States utilizing predominately recycled copper. Using nearly 6,000 copper panels and more than 10,000 copper parts, this 268,000 square-foot building consists of six stories of administration and faculty offices, lecture halls, learning studios, flexible classrooms, clinical suites, gross anatomy facilities, laboratories and conference rooms. To view Multimedia News Release, go to http://www.multivu.com/mnr/61608-copper-development-green-sustainability-video-case-study-credit-architects
Categories // Business  Science and Technology 
Added: 4173 days ago by MultiVuVideos
Runtime: 2m47s | Views: 2587 | Comments: 1
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide. To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
Categories // Business  Science and Technology 
Added: 4105 days ago by MultiVuVideos
Runtime: 1m59s | Views: 1659 | Comments: 1
Not yet rated
 

 

 

The science of bionics helped the more than 1 million Americans with leg amputations take a giant step forward, as the Rehabilitation Institute of Chicago (RIC) revealed clinical applications for the world’s first thought-controlled bionic leg in this week’s New England Journal of Medicine. This innovative technology represents a significant milestone in the rapidly-growing field of bionics. Until now, only thought-controlled bionic arms were available to amputees. To view Multimedia News Release, go to http://www.multivu.com/mnr/63339-rehabilitation-institute-of-chicago-first-thought-controlled-bionic-leg
Categories // Science and Technology 
Added: 4053 days ago by MultiVuVideos
Runtime: 1m5s | Views: 810 | Comments: 0
Not yet rated
 

 

 

Amway North America today launched an online personalized health assessment to simplify the product selection process for consumers. The NUTRILITE® Supplement Recommender is an easy-to-use scientifically-based tool that identifies tailored options for supplementation. The Supplement Recommender was developed by a Nutrilite team of research and clinical scientists based on the world's No. 1 selling vitamins and dietary supplements brand’s product portfolio.* It identifies health, lifestyle and behavior measures associated with nutrition and health outcomes to generate three primary individualized supplement recommendations and up to nine other product options for optimal health. To view Multimedia News Release, go to http://www.multivu.com/mnr/61025-amway-personalized-health-assessment-nutrilite-supplement-recommender
Categories // Business  Science and Technology 
Added: 4024 days ago by MultiVuVideos
Runtime: 1m19s | Views: 1846 | Comments: 1
Not yet rated
 

 

 

Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity. To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
Categories // People and Blog 
Added: 4024 days ago by MultiVuVideos
Runtime: 5m20s | Views: 1576 | Comments: 1
Not yet rated
 

 

 

Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans. To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
Added: 3979 days ago by MultiVuVideos
Runtime: 6m52s | Views: 1454 | Comments: 1
Not yet rated
 

 

 

Page 5 of 9  |  Go to page     |  ««FIRST «Previous  Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2024 ClipMoon.com. All rights reserved.